{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:00:48Z","timestamp":1794031248637,"version":"4.8.0"},"reference-count":252,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A variety of etiologies can cause cerebellar dysfunction, leading to ataxia symptoms. Therefore, the accurate diagnosis of the cause for cerebellar ataxia can be challenging. A step-wise investigation will reveal underlying causes, including nutritional, toxin, immune-mediated, genetic, and degenerative disorders. Recent advances in genetics have identified new genes for both autosomal dominant and autosomal recessive ataxias, and new therapies are on the horizon for targeting specific biological pathways. New diagnostic criteria for degenerative ataxias have been proposed, specifically for multiple system atrophy, which will have a broad impact on the future clinical research in ataxia. In this article, we aim to provide a review focus on symptoms, laboratory testing, neuroimaging, and genetic testing for the diagnosis of cerebellar ataxia causes, with a special emphasis on recent advances. Strategies for the management of cerebellar ataxia is also discussed.<\/jats:p>","DOI":"10.1055\/s-0043-1763511","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:20Z","timestamp":1677283220000},"page":"048-064","source":"Crossref","is-referenced-by-count":17,"title":["Ataxias: Hereditary, Acquired, and Reversible Etiologies"],"prefix":"10.1055","volume":"43","author":[{"given":"Chi-Ying R.","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas"},{"name":"Department of Neurology, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Han","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Neurology, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York"},{"name":"Initiative for Columbia Ataxia and Tremor, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"issue":"04","key":"ref1","first-page":"1036","article-title":"Ataxia","volume":"25","author":"S H Kuo","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2019.05.029","article-title":"Is frontal gait a myth in normal pressure hydrocephalus?","volume":"402","author":"E Morel","year":"2019","journal-title":"J Neurol Sci"},{"issue":"24","key":"ref3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1212\/WNL.0000000000009649","article-title":"Functional gait disorders: a sign-based approach","volume":"94","author":"J Nonnekes","year":"2020","journal-title":"Neurology"},{"issue":"09","key":"ref4","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S1388-2457(00)00362-X","article-title":"Gait analysis in idiopathic normal pressure hydrocephalus\u2013which parameters respond to the CSF tap test?","volume":"111","author":"H Stolze","year":"2000","journal-title":"Clin Neurophysiol"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12311-016-0836-3","article-title":"The initial symptom and motor progression in spinocerebellar ataxias","volume":"16","author":"L Luo","year":"2017","journal-title":"Cerebellum"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"117417","DOI":"10.1016\/j.jns.2021.117417","article-title":"Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: implications for therapy development","volume":"424","author":"M L Chen","year":"2021","journal-title":"J Neurol Sci"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ncl.2020.01.008","article-title":"An overview of the current state and the future of ataxia treatments","volume":"38","author":"K T Kwei","year":"2020","journal-title":"Neurol Clin"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome","volume":"145","author":"P Trouillas","year":"1997","journal-title":"J Neurol Sci"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/mds.20781","article-title":"Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients","volume":"21","author":"T Schmitz-H\u00fcbsch","year":"2006","journal-title":"Mov Disord"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/brain\/awx317","article-title":"The cerebellar cognitive affective\/Schmahmann syndrome scale","volume":"141","author":"F Hoche","year":"2018","journal-title":"Brain"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5334\/tohm.550","article-title":"The impact of compulsivity and impulsivity in cerebellar ataxia: a case series","volume":"10","author":"N Amokrane","year":"2020","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/mds.28121","article-title":"Impulsivity in cerebellar ataxias: testing the cerebellar reward hypothesis in humans","volume":"35","author":"N Amokrane","year":"2020","journal-title":"Mov Disord"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"eaav0581","DOI":"10.1126\/science.aav0581","article-title":"Cerebellar modulation of the reward circuitry and social behavior","volume":"363","author":"I Carta","year":"2019","journal-title":"Science"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1212\/WNL.0000000000200349","article-title":"Impulsivity trait profiles in patients with cerebellar ataxia and parkinson disease","volume":"99","author":"T X Chen","year":"2022","journal-title":"Neurology"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/s41593-018-0228-8","article-title":"Coordinated cerebellar climbing fiber activity signals learned sensorimotor predictions","volume":"21","author":"W Heffley","year":"2018","journal-title":"Nat Neurosci"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neuron.2020.05.021","article-title":"Neural correlates of reinforcement learning in mid-lateral cerebellum","volume":"106","author":"N Sendhilnathan","year":"2020","journal-title":"Neuron"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature21726","article-title":"Cerebellar granule cells encode the expectation of reward","volume":"544","author":"M J Wagner","year":"2017","journal-title":"Nature"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/mds.28670","article-title":"Development and validation of a patient-reported outcome measure of ataxia","volume":"36","author":"J D Schmahmann","year":"2021","journal-title":"Mov Disord"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12311-018-0925-6","article-title":"Time is cerebellum","volume":"17","author":"H Mitoma","year":"2018","journal-title":"Cerebellum"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12311-014-0638-4","article-title":"Ethanol-induced cerebellar ataxia: cellular and molecular mechanisms","volume":"14","author":"M S Dar","year":"2015","journal-title":"Cerebellum"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12311-015-0674-8","article-title":"Effects of ethanol on the cerebellum: advances and prospects","volume":"14","author":"J Luo","year":"2015","journal-title":"Cerebellum"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/archneur.1959.03840060001001","article-title":"A restricted form of cerebellar cortical degeneration occurring in alcoholic patients","volume":"1","author":"M Victor","year":"1959","journal-title":"AMA Arch Neurol"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00344826","article-title":"Computed tomography in alcoholic cerebellar atrophy","volume":"18","author":"A Haubek","year":"1979","journal-title":"Neuroradiology"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"8678","DOI":"10.3390\/ijerph18168678","article-title":"Mechanisms of ethanol-induced cerebellar ataxia: underpinnings of neuronal death in the cerebellum","volume":"18","author":"H Mitoma","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.65.3.370","article-title":"Ataxia induced by small amounts of alcohol","volume":"65","author":"F Setta","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40673-016-0055-1","article-title":"Alcohol-related cerebellar degeneration: not all down to toxicity?","volume":"3","author":"P D Shanmugarajah","year":"2016","journal-title":"Cerebellum Ataxias"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF00313662","article-title":"Improvement of ataxia in alcoholic cerebellar atrophy through alcohol abstinence","volume":"231","author":"H C Diener","year":"1984","journal-title":"J Neurol"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1530-0277.2012.01851.x","article-title":"Gait and balance deficits in chronic alcoholics: no improvement from 10 weeks through 1 year abstinence","volume":"37","author":"G Fein","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.15288\/jsa.1991.52.374","article-title":"The prevalence and extent of vibration sensitivity impairment in men with chronic ethanol abuse","volume":"52","author":"J M Sosenko","year":"1991","journal-title":"J Stud Alcohol"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1474-4422(07)70104-7","article-title":"Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management","volume":"6","author":"G Sechi","year":"2007","journal-title":"Lancet Neurol"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0972-2327.128567","article-title":"Atypical Wernicke's syndrome sans encephalopathy with acute bilateral vision loss due to post-chiasmatic optic tract edema","volume":"17","author":"S D Desai","year":"2014","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1080\/1028415X.2021.1931781","article-title":"Atypical neurological manifestations in Wernicke's encephalopathy due to hyperemesis gravidarum","volume":"25","author":"M B Divya","year":"2022","journal-title":"Nutr Neurosci"},{"issue":"09","key":"ref33","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1212\/WNL.0000000000004294","article-title":"Clinical reasoning: a 61-year-old man with conjugate gaze deviation, hemiparesis, and asymmetric reflexes","volume":"89","author":"C Y Lin","year":"2017","journal-title":"Neurology"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11065-012-9203-4","article-title":"Neuroimaging of Wernicke's encephalopathy and Korsakoff's syndrome","volume":"22","author":"Y C Jung","year":"2012","journal-title":"Neuropsychol Rev"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4103\/aian.AIAN_65_18","article-title":"Wernicke encephalopathy with atypical findings on magnetic resonance imaging","volume":"21","author":"K K Ramineni","year":"2018","journal-title":"Ann Indian Acad Neurol"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3174\/ajnr.A1280","article-title":"MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics","volume":"30","author":"G Zuccoli","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000174951","article-title":"Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients","volume":"76","author":"S H Kuo","year":"2009","journal-title":"Oncology"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nyas.14547","article-title":"Erythrocyte transketolase activity coefficient (ETKAC) assay protocol for the assessment of thiamine status","volume":"1498","author":"K S Jones","year":"2021","journal-title":"Ann N Y Acad Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1192\/bjp.139.2.153","article-title":"Erythrocyte transketolase activity in the Wernicke-Korsakoff syndrome","volume":"139","author":"D Leigh","year":"1981","journal-title":"Br J Psychiatry"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/jn\/128.4.683","article-title":"Thiamine deficiency decreases steady-state transketolase and pyruvate dehydrogenase but not alpha-ketoglutarate dehydrogenase mRNA levels in three human cell types","volume":"128","author":"S R Pekovich","year":"1998","journal-title":"J Nutr"},{"key":"ref41","volume-title":"Wernicke-Korsakoff syndrome","author":"S Akhouri","year":"2022"},{"key":"ref42","volume-title":"Subacute combined degeneration of the spinal cord","author":"Z Qudsiya","year":"2022"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jpba.2004.08.038","article-title":"Determination of thiamine and its phosphorylated forms in human plasma, erythrocytes and urine by HPLC and fluorescence detection: a preliminary study on cancer patients","volume":"37","author":"R Losa","year":"2005","journal-title":"J Pharm Biomed Anal"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1373\/clinchem.2007.099077","article-title":"Rapid HPLC measurement of thiamine and its phosphate esters in whole blood","volume":"54","author":"J Lu","year":"2008","journal-title":"Clin Chem"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/clinchem\/46.5.704","article-title":"Vitamin B(1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay","volume":"46","author":"D Talwar","year":"2000","journal-title":"Clin Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fneur.2017.00312","article-title":"Cerebellar dysfunction in multiple sclerosis","volume":"8","author":"A Wilkins","year":"2017","journal-title":"Front Neurol"},{"issue":"07","key":"ref47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/1352458508101934","article-title":"MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction","volume":"15","author":"V M Anderson","year":"2009","journal-title":"Mult Scler"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.2009.177733","article-title":"Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis","volume":"81","author":"M Calabrese","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1750-3639.2006.00041.x","article-title":"Widespread demyelination in the cerebellar cortex in multiple sclerosis","volume":"17","author":"A Kutzelnigg","year":"2007","journal-title":"Brain Pathol"},{"issue":"09","key":"ref50","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1177\/1352458516674567","article-title":"Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis","volume":"23","author":"A D'Ambrosio","year":"2017","journal-title":"Mult Scler"},{"issue":"08","key":"ref51","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.apmr.2021.12.010","article-title":"Cerebellar contributions to motor and cognitive control in multiple sclerosis\u2730\u2730\u2730","volume":"103","author":"N E Fritz","year":"2022","journal-title":"Arch Phys Med Rehabil"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp-2019-322373","article-title":"Characterisation of ataxia in Sjogren's syndrome","volume":"91","author":"C S Jaques","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"02","key":"ref53","first-page":"81","article-title":"Sjogren's syndrome with acute cerebellar ataxia and massive lymphadenopathy : a case report","volume":"22","author":"Y W Chen","year":"2013","journal-title":"Acta Neurol Taiwan"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s13256-021-03103-x","article-title":"Cerebellar degeneration in primary Sj\u00f6gren syndrome: a case report","volume":"15","author":"S L Chuah","year":"2021","journal-title":"J Med Case Reports"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40673-016-0056-0","article-title":"Progressive cerebellar degeneration revealing Primary Sj\u00f6gren Syndrome: a case report","volume":"3","author":"E Farhat","year":"2016","journal-title":"Cerebellum Ataxias"},{"issue":"15","key":"ref56","doi-asserted-by":"crossref","first-page":"e138619","DOI":"10.1172\/jci.insight.138619","article-title":"Multiple system atrophy pathology is associated with primary Sj\u00f6gren's syndrome","volume":"5","author":"K S Conway","year":"2020","journal-title":"JCI Insight"},{"issue":"04","key":"ref57","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.108","article-title":"Gluten sensitivity in sporadic and hereditary cerebellar ataxia","volume":"49","author":"K O Bushara","year":"2001","journal-title":"Ann Neurol"},{"issue":"11","key":"ref58","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/jnnp-2018-318215","article-title":"Serum antigliadin antibodies in cerebellar ataxias: a systematic review and meta-analysis","volume":"89","author":"C Y Lin","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40673-021-00139-z","article-title":"Recognition and management of rapid-onset gluten ataxias: case series","volume":"8","author":"L Newrick","year":"2021","journal-title":"Cerebellum Ataxias"},{"key":"ref60","first-page":"14","article-title":"Anti-gliadin antibodies identify celiac patients overlooked by tissue transglutaminase antibodies","volume":"72","author":"B C Benson","year":"2013","journal-title":"Hawaii J Med Public Health"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40673-015-0034-y","article-title":"Guidelines for treatment of immune-mediated cerebellar ataxias","volume":"2","author":"H Mitoma","year":"2015","journal-title":"Cerebellum Ataxias"},{"issue":"02","key":"ref62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5812\/ijem.4174","article-title":"Hashimoto encephalopathy: a rare intricate syndrome","volume":"10","author":"J Payer","year":"2012","journal-title":"Int J Endocrinol Metab"},{"issue":"03","key":"ref63","first-page":"42","article-title":"Progressive non-familial adult onset cerebellar degeneration: an unusual occurrence with Hashimoto's thyroiditis","volume":"48","author":"R S Rao","year":"2018","journal-title":"Psychopharmacol Bull"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jnnp.71.1.81","article-title":"Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis","volume":"71","author":"M Selim","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.WNL.0000048660.71390.C6","article-title":"Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy","volume":"60","author":"F Ferracci","year":"2003","journal-title":"Neurology"},{"issue":"02","key":"ref66","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jnnp.2006.093005","article-title":"Hashimoto's encephalopathy presenting with progressive cerebellar ataxia","volume":"78","author":"H Nakagawa","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"02","key":"ref67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.63.2.197","article-title":"Steroid-responsive encephalopathy associated with autoimmune thyroiditis","volume":"63","author":"P Castillo","year":"2006","journal-title":"Arch Neurol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"bcr0920103332","DOI":"10.1136\/bcr.09.2010.3332","article-title":"Successful response to intravenous immunoglobulin as rescue therapy in a patient with Hashimoto's encephalopathy","volume":"2010","author":"R Cornejo","year":"2010","journal-title":"BMJ Case Rep"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1212\/NXI.0000000000000255","article-title":"Autoantibodies against glutamate receptor \u03b42 after allogenic stem cell transplantation","volume":"3","author":"R Miske","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"04","key":"ref70","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.braindev.2006.09.004","article-title":"Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody","volume":"29","author":"T Shiihara","year":"2007","journal-title":"Brain Dev"},{"key":"ref71","volume-title":"Paraneoplastic cerebellar degeneration","author":"R Aly","year":"2022"},{"issue":"10","key":"ref72","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/archneurol.2011.128","article-title":"Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond","volume":"68","author":"A McKeon","year":"2011","journal-title":"Arch Neurol"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp-2014-308074","article-title":"Pathological findings of anti-Yo cerebellar degeneration with Holmes tremor","volume":"86","author":"D Rydz","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12974-015-0358-9","article-title":"\u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook","volume":"12","author":"S Jarius","year":"2015","journal-title":"J Neuroinflammation"},{"issue":"05","key":"ref75","doi-asserted-by":"crossref","first-page":"e200018","DOI":"10.1212\/NXI.0000000000200018","article-title":"Cerebellar ataxia with anti-DNER antibodies: outcomes and immunologic features","volume":"9","author":"E Peter","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"ref76","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.3390\/ijms21103701","article-title":"Neurological syndromes associated with anti-GAD antibodies","volume":"21","author":"M Dade","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"07","key":"ref77","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00415-020-09807-2","article-title":"Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies","volume":"267","author":"B Joubert","year":"2020","journal-title":"J Neurol"},{"issue":"04","key":"ref78","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"M P Malter","year":"2010","journal-title":"Ann Neurol"},{"issue":"02","key":"ref79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients","volume":"58","author":"J Honnorat","year":"2001","journal-title":"Arch Neurol"},{"issue":"08","key":"ref80","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy","volume":"71","author":"H Ari\u00f1o","year":"2014","journal-title":"JAMA Neurol"},{"issue":"03","key":"ref81","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000369784","article-title":"GAD antibody-associated late-onset cerebellar ataxia in two female siblings","volume":"6","author":"J Kuchling","year":"2014","journal-title":"Case Rep Neurol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"A Saiz","year":"2008","journal-title":"Brain"},{"issue":"06","key":"ref83","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mus.20653","article-title":"Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome","volume":"34","author":"A J Espay","year":"2006","journal-title":"Muscle Nerve"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"A McKeon","year":"2012","journal-title":"Arch Neurol"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.50.1.94","article-title":"Stiff-man syndrome in a woman with breast cancer: an uncommon central nervous system paraneoplastic syndrome","volume":"50","author":"L Rosin","year":"1998","journal-title":"Neurology"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jnnp.67.1.126","article-title":"Paraneoplastic stiff limb syndrome","volume":"67","author":"I E Silverman","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.athoracsur.2004.02.076","article-title":"Stiff man syndrome with thymoma","volume":"80","author":"H Tanaka","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"01","key":"ref88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/jnnp.2004.036558","article-title":"Stiff person syndrome with eye movement abnormality, myasthenia gravis, and thymoma","volume":"76","author":"S Thomas","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"26","key":"ref89","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome","volume":"345","author":"M C Dalakas","year":"2001","journal-title":"N Engl J Med"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"bcr2013202314","DOI":"10.1136\/bcr-2013-202314","article-title":"Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis","volume":"2014","author":"Z Georgieva","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"11","key":"ref91","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2015.2378","article-title":"Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults","volume":"72","author":"A L Jones","year":"2015","journal-title":"JAMA Neurol"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/14734220260418457","article-title":"Acute cerebellitis","volume":"1","author":"Y Sawaishi","year":"2002","journal-title":"Cerebellum"},{"issue":"12","key":"ref93","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/emj.2009.079376","article-title":"Acute cerebellar ataxia in childhood: initial approach in the emergency department","volume":"27","author":"A A Salas","year":"2010","journal-title":"Emerg Med J"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1824-7288-40-57","article-title":"Acute cerebellitis in varicella: a ten year case series and systematic review of the literature","volume":"40","author":"E Bozzola","year":"2014","journal-title":"Ital J Pediatr"},{"issue":"10","key":"ref95","first-page":"e18505","article-title":"Acute COVID-19 cerebellitis: a rare neurological manifestation of COVID-19 infection","volume":"13","author":"S V Malayala","year":"2021","journal-title":"Cureus"},{"key":"ref96","first-page":"X211066755","article-title":"Acute cerebellar ataxia associated with COVID-19 infection in a 5-year-old boy","volume":"8","author":"K A O'Neill","year":"2021","journal-title":"Child Neurol Open"},{"issue":"01","key":"ref97","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jemermed.2020.10.010","article-title":"Acute cerebellar ataxia in COVID-19 infection: a case report","volume":"60","author":"A Povlow","year":"2021","journal-title":"J Emerg Med"},{"issue":"04","key":"ref98","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mdc3.13208","article-title":"Acute post-infectious cerebellar ataxia due to COVID-19","volume":"8","author":"L R Tomar","year":"2021","journal-title":"Mov Disord Clin Pract (Hoboken)"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12879-021-05987-y","article-title":"Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report","volume":"21","author":"J Werner","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200816","article-title":"Cytotoxic edema involving the corpus callosum and middle cerebellar peduncles in a young patient with mild COVID-19","author":"K Altmann","year":"2022","journal-title":"Neurology"},{"issue":"12","key":"ref101","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s40263-014-0200-4","article-title":"Drug-induced cerebellar ataxia: a systematic review","volume":"28","author":"J van Gaalen","year":"2014","journal-title":"CNS Drugs"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fneur.2018.00119","article-title":"Amiodarone: a newly discovered association with bilateral vestibulopathy","volume":"9","author":"R G\u00fcrkov","year":"2018","journal-title":"Front Neurol"},{"issue":"03","key":"ref103","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12603-020-1475-4","article-title":"Amiodarone-induced ataxia: a case report of severe cerebellar dysfunction and review of literature","volume":"25","author":"S Sarrazin","year":"2021","journal-title":"J Nutr Health Aging"},{"issue":"03","key":"ref104","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1432-2277.1993.tb00642.x","article-title":"Dysarthria and cerebellar ataxia: late occurrence of severe neurotoxicity in a liver transplant recipient","volume":"6","author":"L S Belli","year":"1993","journal-title":"Transpl Int"},{"issue":"02","key":"ref105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejpn.2006.01.002","article-title":"Tacrolimus induced subacute cerebellar ataxia","volume":"10","author":"J Kaleyias","year":"2006","journal-title":"Eur J Paediatr Neurol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/OAEM.S241501","article-title":"Cyclosporine-A-based immunosuppressive therapy-induced neurotoxicity: a case report","volume":"12","author":"A Teimouri","year":"2020","journal-title":"Open Access Emerg Med"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(84)91556-3","article-title":"Association between cyclosporin neurotoxicity and hypomagnesaemia","volume":"2","author":"C B Thompson","year":"1984","journal-title":"Lancet"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jns.2009.06.011","article-title":"Reversible metronidazole-induced cerebellar toxicity in a multiple transplant recipient","volume":"285","author":"T D Graves","year":"2009","journal-title":"J Neurol Sci"},{"issue":"01","key":"ref109","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200201033460117","article-title":"Reversible metronidazole-induced lesions of the cerebellar dentate nuclei","volume":"346","author":"B K Woodruff","year":"2002","journal-title":"N Engl J Med"},{"issue":"05","key":"ref110","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/02841860701666089","article-title":"Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature","volume":"47","author":"P Hamberg","year":"2008","journal-title":"Acta Oncol"},{"issue":"03","key":"ref111","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jnci\/djj034","article-title":"Central nervous system toxicity induced by irinotecan","volume":"98","author":"P Hamberg","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"04","key":"ref112","first-page":"1014","article-title":"High-dose cytarabine neurotoxicity: MR findings during the acute phase","volume":"14","author":"D J Vaughn","year":"1993","journal-title":"AJNR Am J Neuroradiol"},{"issue":"01","key":"ref113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.wnf.0000150871.52253.b7","article-title":"The syndrome of irreversible lithium-effectuated neurotoxicity","volume":"28","author":"K R Munshi","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"05","key":"ref114","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2215\/CJN.10021014","article-title":"Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP workgroup","volume":"10","author":"B S Decker","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"01","key":"ref115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14581\/jer.17004","article-title":"Can therapeutic-range chronic phenytoin administration cause cerebellar ataxia?","volume":"7","author":"H J Moon","year":"2017","journal-title":"J Epilepsy Res"},{"issue":"07","key":"ref116","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/acn3.51576","article-title":"Clinicopathological correlates of pyramidal signs in multiple system atrophy","volume":"9","author":"C R Lin","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"03","key":"ref117","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410440324","article-title":"Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein","volume":"44","author":"P H Tu","year":"1998","journal-title":"Ann Neurol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2011.11.017","article-title":"Clinical subtypes of anterocollis in parkinsonian syndromes","volume":"315","author":"G J Revuelta","year":"2012","journal-title":"J Neurol Sci"},{"issue":"14","key":"ref119","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1212\/WNL.0000000000008208","article-title":"Stridor in multiple system atrophy: consensus statement on diagnosis, prognosis, and treatment","volume":"93","author":"P Cortelli","year":"2019","journal-title":"Neurology"},{"issue":"09","key":"ref120","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/brain\/awz189","article-title":"Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study","volume":"142","author":"Y Miki","year":"2019","journal-title":"Brain"},{"issue":"06","key":"ref121","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"G K Wenning","year":"2022","journal-title":"Mov Disord"},{"issue":"09","key":"ref122","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"S Gilman","year":"2008","journal-title":"Neurology"},{"issue":"05","key":"ref123","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients","volume":"85","author":"S Koga","year":"2015","journal-title":"Neurology"},{"issue":"05","key":"ref124","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","article-title":"Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy","volume":"53","author":"S Braune","year":"1999","journal-title":"Neurology"},{"issue":"09","key":"ref125","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mds.28126","article-title":"Skin biopsy may help to distinguish multiple system atrophy-Parkinsonism from Parkinson's disease with orthostatic hypotension","volume":"35","author":"V Donadio","year":"2020","journal-title":"Mov Disord"},{"key":"ref126","first-page":"167038","article-title":"Clinical utility of skin biopsy in differentiating between Parkinson's disease and multiple system atrophy","volume":"2015","author":"R Haga","year":"2015","journal-title":"Parkinsons Dis"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"M Shahnawaz","year":"2020","journal-title":"Nature"},{"issue":"12","key":"ref128","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00702-017-1791-y","article-title":"Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms","volume":"124","author":"S Eschlb\u00f6ck","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"issue":"01","key":"ref129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10286-015-0271-4","article-title":"Multiple system atrophy: using clinical pharmacology to reveal pathophysiology","volume":"25","author":"J Jordan","year":"2015","journal-title":"Clin Auton Res"},{"issue":"01","key":"ref130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mdc3.12145","article-title":"Current concepts in the treatment of multiple system atrophy","volume":"2","author":"S Perez-Lloret","year":"2015","journal-title":"Mov Disord Clin Pract (Hoboken)"},{"issue":"06","key":"ref131","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/14656566.2019.1574746","article-title":"Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases","volume":"20","author":"S P\u00e9rez-Lloret","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"02","key":"ref132","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1474-4422(03)00662-8","article-title":"Multiple system atrophy","volume":"3","author":"G K Wenning","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref133","volume-title":"RFC1 CANVAS \/ Spectrum Disorder","author":"A Cortese","year":"1993"},{"issue":"04","key":"ref134","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/jnnp-2020-325092","article-title":"RFC1-related ataxia is a mimic of early multiple system atrophy","volume":"92","author":"R Sullivan","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"08","key":"ref135","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2310\/JIM.0b013e3181af59c4","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical phenotype, diagnosis, and treatment","volume":"57","author":"M A Leehey","year":"2009","journal-title":"J Investig Med"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/brain\/awh535","article-title":"The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA study group","volume":"128","author":"C Kamm","year":"2005","journal-title":"Brain"},{"issue":"01","key":"ref137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"I Litvan","year":"1996","journal-title":"Neurology"},{"issue":"06","key":"ref138","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"G U H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"issue":"06","key":"ref139","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnen\/59.6.513","article-title":"A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy","volume":"59","author":"K Ishizawa","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clineuro.2013.12.011","article-title":"Cerebellar dentate nucleus in progressive supranuclear palsy","volume":"118","author":"N Sawa","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"issue":"14","key":"ref141","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/mds.23298","article-title":"Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study","volume":"25","author":"Y Shirota","year":"2010","journal-title":"Mov Disord"},{"issue":"05","key":"ref142","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/neup.12012","article-title":"An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement","volume":"33","author":"Y Iwasaki","year":"2013","journal-title":"Neuropathology"},{"issue":"09","key":"ref143","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/mds.22583","article-title":"Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study","volume":"24","author":"M Kanazawa","year":"2009","journal-title":"Mov Disord"},{"issue":"05","key":"ref144","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mds.26499","article-title":"Cerebellar ataxia in progressive supranuclear palsy: an autopsy study of PSP-C","volume":"31","author":"S Koga","year":"2016","journal-title":"Mov Disord"},{"issue":"01","key":"ref145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14802\/jmd.19061","article-title":"Progressive supranuclear palsy with predominant cerebellar ataxia","volume":"13","author":"S Ando","year":"2020","journal-title":"J Mov Disord"},{"issue":"09","key":"ref147","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/mds.29152","article-title":"Prevalence and treatments of movement disorders in prion diseases: a longitudinal cohort study","volume":"37","author":"D Sequeira","year":"2022","journal-title":"Mov Disord"},{"issue":"11","key":"ref148","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/jnnp.2006.088930","article-title":"Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK","volume":"77","author":"S A Cooper","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"02","key":"ref149","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/jamaneurol.2016.3426","article-title":"Cerebellar ataxia and hearing impairment","volume":"74","author":"C Y Lin","year":"2017","journal-title":"JAMA Neurol"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/postgradmedj-2018-135566","article-title":"Cerebellar ataxia as a first manifestation of Creutzfeldt-Jakob disease in two cousins","volume":"94","author":"M Waliszewska-Pros\u00f3\u0142","year":"2018","journal-title":"Postgrad Med J"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5334\/tohm.72","article-title":"Dressing apraxia as initial manifestation of Creutzfeldt-Jakob disease","volume":"10","author":"J G Heckmann","year":"2020","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"01","key":"ref152","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/practneurol-2018-001935","article-title":"RT-QuIC: a new test for sporadic CJD","volume":"19","author":"A JE Green","year":"2019","journal-title":"Pract Neurol"},{"issue":"02","key":"ref153","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"L I McGuire","year":"2012","journal-title":"Ann Neurol"},{"issue":"11","key":"ref154","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/ncpneuro0319","article-title":"An approach to the patient with late-onset cerebellar ataxia","volume":"2","author":"B L Fogel","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"issue":"01","key":"ref155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2011-000108","article-title":"A practical approach to late-onset cerebellar ataxia: putting the disorder with lack of order into order","volume":"12","author":"J van Gaalen","year":"2012","journal-title":"Pract Neurol"},{"key":"ref156","volume-title":"Evaluation and Management of Ataxic Disorders: An Overview for Physicians","author":"S Perlman","year":"2016"},{"issue":"01","key":"ref157","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(09)70305-9","article-title":"Sporadic ataxia with adult onset: classification and diagnostic criteria","volume":"9","author":"T Klockgether","year":"2010","journal-title":"Lancet Neurol"},{"issue":"04","key":"ref158","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.53.4.297","article-title":"Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology","volume":"53","author":"T Klockgether","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref159","first-page":"2143","volume-title":"Idiopathic late onset cerebellar ataxia (ILOCA), and cerebellar plus syndrome","author":"S Tsuji","year":"2013"},{"issue":"01","key":"ref160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/345488","article-title":"A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]","volume":"72","author":"J C van Swieten","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5334\/tohm.436","article-title":"Spinocerebellar ataxia 27: a review and characterization of an evolving phenotype","volume":"8","author":"C L Groth","year":"2018","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"01","key":"ref162","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajhg.2022.11.015","article-title":"An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50\/ATX-FGF14","volume":"110","author":"H Rafehi","year":"2023","journal-title":"Am J Hum Genet"},{"issue":"02","key":"ref163","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2207406","article-title":"Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia","volume":"388","author":"D Pellerin","year":"2023","journal-title":"N Engl J Med"},{"issue":"04","key":"ref164","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1756285612471415","article-title":"The balance and gait disorder of essential tremor: what does this mean for patients?","volume":"6","author":"D Arkadir","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"key":"ref165","first-page":"9","article-title":"Ataxic gait in essential tremor: a disease-associated feature?","volume":"9","author":"A K Rao","year":"2019","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"03","key":"ref166","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1474-4422(19)30398-9","article-title":"Essential tremor-plus: a controversial new concept","volume":"19","author":"E D Louis","year":"2020","journal-title":"Lancet Neurol"},{"issue":"06","key":"ref167","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mds.28502","article-title":"Increased climbing fiber lateral crossings on purkinje cell dendrites in the cerebellar hemisphere in essential tremor","volume":"36","author":"Y C Wu","year":"2021","journal-title":"Mov Disord"},{"issue":"06","key":"ref168","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s12311-021-01263-6","article-title":"Essential tremor versus \u201cET-plus\u201d: a detailed postmortem study of cerebellar pathology","volume":"20","author":"J T Gionco","year":"2021","journal-title":"Cerebellum"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5334\/tohm.138","article-title":"Four essential tremor cases with moderately impaired gait: how impaired can gait be in this disease?","volume":"3","author":"E D Louis","year":"2013","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"581703","DOI":"10.3389\/fneur.2020.581703","article-title":"Prospective longitudinal study of gait and balance in a cohort of elderly essential tremor patients","volume":"11","author":"H Dowd","year":"2020","journal-title":"Front Neurol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5334\/tohm.346","article-title":"Postural tremor and ataxia progression in spinocerebellar ataxias","volume":"7","author":"S R Gan","year":"2017","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"03","key":"ref172","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12311-019-01016-6","article-title":"Tremor in the degenerative cerebellum: towards the understanding of brain circuitry for tremor","volume":"18","author":"R Y Lai","year":"2019","journal-title":"Cerebellum"},{"issue":"01","key":"ref173","first-page":"227","article-title":"Superficial siderosis of the CNS: MR diagnosis and clinical findings","volume":"14","author":"M Bracchi","year":"1993","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref174","first-page":"1051","article-title":"Superficial siderosis of the central nervous system","volume":"118","author":"J M Fearnley","year":"1995","journal-title":"Brain"},{"issue":"01","key":"ref175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40673-021-00133-5","article-title":"Idiopathic superficial siderosis of the central nervous system","volume":"8","author":"S Meshkat","year":"2021","journal-title":"Cerebellum Ataxias"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1172-9-15","article-title":"A novel recurrent mutation in ATP1A3 causes CAPOS syndrome","volume":"9","author":"M K Demos","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"ref177","first-page":"71.e1","article-title":"The genetic homogeneity of CAPOS syndrome: four new patients with the c.2452G>A (p.Glu818Lys) mutation in the ATP1A3 gene","volume":"59","author":"R P Maas","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"05","key":"ref178","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jmg.33.5.419","article-title":"Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome","volume":"33","author":"P Nicolaides","year":"1996","journal-title":"J Med Genet"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"e20656","DOI":"10.1200\/JCO.2016.34.15_suppl.e20656","article-title":"Ataxia in long term survivors of lung cancer after whole brain radiation therapy (WBRT)","volume":"34","author":"V Kumar","year":"2016","journal-title":"J Clin Oncol"},{"issue":"01","key":"ref180","first-page":"100","article-title":"Radiation therapy-related ataxia associated with FDG-PET cerebellar hypometabolism","volume":"110","author":"D Renard","year":"2010","journal-title":"Acta Neurol Belg"},{"issue":"03","key":"ref181","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1590\/1806-9282.66.3.375","article-title":"Severe cerebellar degeneration and Chiari I malformation - speculative pathophysiology based on a systematic review","volume":"66","author":"A F Joaquim","year":"2020","journal-title":"Rev Assoc Med Bras"},{"issue":"06","key":"ref182","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaneurol.2019.0423","article-title":"Prevalence of carriers of intermediate and pathological polyglutamine disease-associated alleles among large population-based cohorts","volume":"76","author":"S L Gardiner","year":"2019","journal-title":"JAMA Neurol"},{"issue":"02","key":"ref183","doi-asserted-by":"crossref","first-page":"fcac030","DOI":"10.1093\/braincomms\/fcac030","article-title":"New spinocerebellar ataxia subtype caused by SAMD9L mutation triggering mitochondrial dysregulation (SCA49)","volume":"4","author":"M Corral-Juan","year":"2022","journal-title":"Brain Commun"},{"issue":"03","key":"ref184","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0404.1995.tb00430.x","article-title":"Hereditary ataxias and paraplegias in Valle d'Aosta, Italy: a study of prevalence and disability","volume":"91","author":"M Leone","year":"1995","journal-title":"Acta Neurol Scand"},{"issue":"03","key":"ref185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies","volume":"42","author":"L Ruano","year":"2014","journal-title":"Neuroepidemiology"},{"issue":"05","key":"ref186","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/WNL.58.5.702","article-title":"Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis","volume":"58","author":"B P van de Warrenburg","year":"2002","journal-title":"Neurology"},{"issue":"05","key":"ref187","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis","volume":"3","author":"L Sch\u00f6ls","year":"2004","journal-title":"Lancet Neurol"},{"issue":"10","key":"ref188","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","article-title":"Spinocerebellar ataxias: prospects and challenges for therapy development","volume":"14","author":"T Ashizawa","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"01","key":"ref189","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"T Klockgether","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"ref190","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrn.2017.92","article-title":"Polyglutamine spinocerebellar ataxias - from genes to potential treatments","volume":"18","author":"H L Paulson","year":"2017","journal-title":"Nat Rev Neurosci"},{"issue":"01","key":"ref191","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jmg.2007.053942","article-title":"Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16","volume":"45","author":"A Iwaki","year":"2008","journal-title":"J Med Genet"},{"issue":"04","key":"ref192","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10048-009-0197-x","article-title":"SCA27 caused by a chromosome translocation: further delineation of the phenotype","volume":"10","author":"D Misceo","year":"2009","journal-title":"Neurogenetics"},{"issue":"05","key":"ref193","first-page":"973","article-title":"Anticipation: an old idea in new genes","volume":"59","author":"M G McInnis","year":"1996","journal-title":"Am J Hum Genet"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2015.04.040","article-title":"Infantile spinocerebellar ataxia type 7: case report and a review of the literature","volume":"354","author":"K C Donis","year":"2015","journal-title":"J Neurol Sci"},{"issue":"07","key":"ref195","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/acn3.51370","article-title":"Spinocerebellar ataxia clinical trials: opportunities and challenges","volume":"8","author":"S M Brooker","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"ref196","doi-asserted-by":"crossref","first-page":"116878","DOI":"10.1016\/j.jns.2020.116878","article-title":"Dysphagia in spinocerebellar ataxias type 1, 2, 3 and 6","volume":"415","author":"C Y Yang","year":"2020","journal-title":"J Neurol Sci"},{"issue":"03","key":"ref197","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mds.27258","article-title":"C9orf72 repeat expansions as genetic modifiers for depression in spinocerebellar ataxias","volume":"33","author":"K P Figueroa","year":"2018","journal-title":"Mov Disord"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2015.11.021","article-title":"Depression and clinical progression in spinocerebellar ataxias","volume":"22","author":"R Y Lo","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"ref199","doi-asserted-by":"crossref","first-page":"e01414","DOI":"10.1002\/brb3.1414","article-title":"Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population","volume":"9","author":"S J Chen","year":"2019","journal-title":"Brain Behav"},{"issue":"02","key":"ref200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archneur.58.2.296","article-title":"Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family","volume":"58","author":"K Gwinn-Hardy","year":"2001","journal-title":"Arch Neurol"},{"issue":"08","key":"ref201","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1111\/ene.15339","article-title":"Long-term efficacy of bilateral subthalamic deep brain stimulation in the parkinsonism of SCA 3: a rare case report","volume":"29","author":"M C Kuo","year":"2022","journal-title":"Eur J Neurol"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1750-1172-8-177","article-title":"Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study","volume":"8","author":"T Ashizawa","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"ref203","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1212\/WNL.0b013e31822e7ca0","article-title":"The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study","volume":"77","author":"H Jacobi","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"ref204","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","article-title":"Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study","volume":"14","author":"H Jacobi","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2020.02.004","article-title":"The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3","volume":"72","author":"S R Gan","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"ref206","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parkreldis.2022.02.025","article-title":"The association between educational attainment and SCA 3 age of onset and disease course","volume":"98","author":"K Iannuzzelli","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"issue":"03","key":"ref207","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14802\/jmd.16028","article-title":"Episodic ataxias: clinical and genetic features","volume":"9","author":"K D Choi","year":"2016","journal-title":"J Mov Disord"},{"issue":"10","key":"ref208","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3390\/ijms21103603","article-title":"Clinical and genetic overview of paroxysmal movement disorders and episodic ataxias","volume":"21","author":"G Garone","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref209","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/awu012","article-title":"Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation","volume":"137","author":"T D Graves","year":"2014","journal-title":"Brain"},{"issue":"02","key":"ref210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.nurt.2007.01.014","article-title":"Episodic ataxia type 2","volume":"4","author":"M Strupp","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"01","key":"ref211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.WNL.0000101675.61074.50","article-title":"Clinical spectrum of episodic ataxia type 2","volume":"62","author":"J Jen","year":"2004","journal-title":"Neurology"},{"issue":"06","key":"ref212","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/01.wnl.0000176069.64200.28","article-title":"Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A","volume":"65","author":"P Imbrici","year":"2005","journal-title":"Neurology"},{"issue":"23","key":"ref213","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1212\/WNL.0000000000002743","article-title":"Pearls & Oy-sters: episodic ataxia type 2: case report and review of the literature","volume":"86","author":"E L Guterman","year":"2016","journal-title":"Neurology"},{"key":"ref214","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/brain\/awm126","article-title":"Primary episodic ataxias: diagnosis, pathogenesis and treatment","volume":"130","author":"J C Jen","year":"2007","journal-title":"Brain"},{"issue":"05","key":"ref215","first-page":"533","article-title":"Acetazolamide-responsive ataxia","volume":"32","author":"V Kotagal","year":"2012","journal-title":"Semin Neurol"},{"issue":"03","key":"ref216","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0b013e318225ab07","article-title":"A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias","volume":"77","author":"M Strupp","year":"2011","journal-title":"Neurology"},{"issue":"07","key":"ref217","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJMra1006610","article-title":"The autosomal recessive cerebellar ataxias","volume":"366","author":"M Anheim","year":"2012","journal-title":"N Engl J Med"},{"key":"ref218","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-444-64189-2.00005-6","article-title":"Recessive ataxias","volume":"155","author":"M Synofzik","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"04","key":"ref219","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.neuron.2019.01.049","article-title":"Autosomal recessive cerebellar ataxias: paving the way toward targeted molecular therapies","volume":"101","author":"M Synofzik","year":"2019","journal-title":"Neuron"},{"issue":"06","key":"ref220","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.25084","article-title":"A recessive ataxia diagnosis algorithm for the next generation sequencing era","volume":"82","author":"M Renaud","year":"2017","journal-title":"Ann Neurol"},{"issue":"06","key":"ref221","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s12311-019-01052-2","article-title":"The classification of autosomal recessive cerebellar ataxias: a consensus statement from the Society for Research on the Cerebellum and Ataxias Task Force","volume":"18","author":"M Beaudin","year":"2019","journal-title":"Cerebellum"},{"issue":"01","key":"ref222","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/nmt.15.73","article-title":"Emerging therapies in Friedreich's ataxia","volume":"6","author":"T V Aranca","year":"2016","journal-title":"Neurodegener Dis Manag"},{"issue":"12","key":"ref223","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/14737175.2020.1821654","article-title":"Emerging therapies in Friedreich's ataxia","volume":"20","author":"T A Zesiewicz","year":"2020","journal-title":"Expert Rev Neurother"},{"issue":"01","key":"ref224","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13023-020-01475-9","article-title":"Onset features and time to diagnosis in Friedreich's ataxia","volume":"15","author":"E Indelicato","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40673-017-0062-x","article-title":"Friedreich ataxia: current status and future prospects","volume":"4","author":"K B\u00fcrk","year":"2017","journal-title":"Cerebellum Ataxias"},{"issue":"09","key":"ref226","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14737175.2017.1356721","article-title":"Pharmacological therapeutics in Friedreich ataxia: the present state","volume":"17","author":"C Strawser","year":"2017","journal-title":"Expert Rev Neurother"},{"issue":"01","key":"ref227","first-page":"39","article-title":"Microvascular pathology in Friedreich cardiomyopathy","volume":"35","author":"A H Koeppen","year":"2020","journal-title":"Histol Histopathol"},{"issue":"02","key":"ref228","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/NEN.0000000000000160","article-title":"Friedreich ataxia: failure of GABA-ergic and glycinergic synaptic transmission in the dentate nucleus","volume":"74","author":"A H Koeppen","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"issue":"01","key":"ref229","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-010-0675-0","article-title":"Pathology and pathogenesis of sensory neuropathy in Friedreich's ataxia","volume":"120","author":"J A Morral","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"01","key":"ref230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bmb\/ldx034","article-title":"Friedreich's ataxia: clinical features, pathogenesis and management","volume":"124","author":"A Cook","year":"2017","journal-title":"Br Med Bull"},{"issue":"14","key":"ref231","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1212\/WNL.0000000000200913","article-title":"Natural history of Friedreich's ataxia: heterogeneity of neurological progression and consequences for clinical trial design","volume":"99","author":"C Rummey","year":"2022","journal-title":"Neurology"},{"issue":"04","key":"ref232","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-019-0372-4","article-title":"Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia","volume":"51","author":"A Cortese","year":"2019","journal-title":"Nat Genet"},{"issue":"05","key":"ref233","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/brain\/awab072","article-title":"RFC1 expansions are a common cause of idiopathic sensory neuropathy","volume":"144","author":"R Curr\u00f2","year":"2021","journal-title":"Brain"},{"issue":"09","key":"ref234","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1212\/WNL.0000000000011528","article-title":"Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease","volume":"96","author":"A Trasch\u00fctz","year":"2021","journal-title":"Neurology"},{"issue":"01","key":"ref235","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1212\/WNL.0000000000004064","article-title":"Clinical reasoning: a 58-year-old man with progressive ptosis and walking difficulty","volume":"89","author":"P H Kuo","year":"2017","journal-title":"Neurology"},{"issue":"20","key":"ref236","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0000000000007507","article-title":"Clinical reasoning: refractory status epilepticus in a primigravida","volume":"92","author":"H Shi","year":"2019","journal-title":"Neurology"},{"key":"ref237","first-page":"159","article-title":"Ataxia-telangiectasia: future prospects","volume":"7","author":"M W Chaudhary","year":"2014","journal-title":"Appl Clin Genet"},{"issue":"02","key":"ref238","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(98)00027-9","article-title":"Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update","volume":"47","author":"M F Lavin","year":"1998","journal-title":"Radiother Oncol"},{"issue":"02","key":"ref239","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/bjc.2011.534","article-title":"Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia","volume":"106","author":"P J Byrd","year":"2012","journal-title":"Br J Cancer"},{"issue":"01","key":"ref240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"C Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"03","key":"ref241","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajhg.2015.01.005","article-title":"Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4","volume":"96","author":"J Bras","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"01","key":"ref242","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1212\/NXG.0000000000000049","article-title":"Expanding the ataxia with oculomotor apraxia type 4 phenotype","volume":"2","author":"M Paucar","year":"2016","journal-title":"Neurol Genet"},{"key":"ref243","volume-title":"Ataxia with oculomotor apraxia type 1","author":"P Coutinho","year":"1993"},{"key":"ref244","volume-title":"Ataxia with oculomotor apraxia type 2","author":"M C Moreira","year":"1993"},{"key":"ref245","volume-title":"Niemann-Pick disease type C","author":"M Patterson","year":"1993"},{"key":"ref246","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5334\/tohm.446","article-title":"Abnormal vertical eye movements as a clue for diagnosis of Niemann-Pick type C","volume":"8","author":"D K Gupta","year":"2018","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref247","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.seizure.2019.08.012","article-title":"The best evidence for progressive myoclonic epilepsy: a pathway to precision therapy","volume":"71","author":"A Orsini","year":"2019","journal-title":"Seizure"},{"issue":"07","key":"ref248","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome - features, mechanisms and management","volume":"12","author":"R J Hagerman","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"ref249","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.parkreldis.2019.05.010","article-title":"The spectrum of tremor among carriers of the FMR1 premutation with or without the fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"65","author":"T Fay-Karmon","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"18","key":"ref250","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria","volume":"79","author":"E Apartis","year":"2012","journal-title":"Neurology"},{"issue":"22","key":"ref251","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1212\/WNL.0000000000003979","article-title":"White matter microstructure, cognition, and molecular markers in fragile X premutation females","volume":"88","author":"A L Shelton","year":"2017","journal-title":"Neurology"},{"issue":"04","key":"ref252","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"J Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"14","key":"ref253","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: Main syndrome and antibody effects","volume":"88","author":"M Hara","year":"2017","journal-title":"Neurology"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1763511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T18:44:26Z","timestamp":1701974666000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1763511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":252,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2023,4,3]]},"published-print":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1763511","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"value":"0271-8235","type":"print"},{"value":"1098-9021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}